Invitation to the presentation of ALK’s first quarter outcomes on Friday 3 Could 2024

ALK (ALKB:DC / OMX: ALK B / AKBLF) will publish its first quarter ends in the morning of three Could 2024.

Later identical day, the corporate will host a presentation for traders and analysts at 12:30 CET, the place ALK’s administration will touch upon the primary quarter outcomes and outlook and be obtainable for questions.

ALK shall be represented by Peter Halling, President & CEO, Claus Steensen Sølje, CFO and Per Plotnikof, VP, Head of IR.

Dwell audio webcast

The assembly shall be audio webcasted reside and be obtainable for replay on ALK’s web site https://ir.alk.net

Convention name

In case you want to take part by way of phone, please register for the convention name through the use of this hyperlink: Registration – ALK Q1 2024 – telephone conference and observe the directions. You’ll obtain an e mail from [email protected] with dial-in particulars, together with a passcode and a pin code. Please make certain to whitelist [email protected] 
and/or examine your spam filter. We advise you to register on the day earlier than the decision on the newest.

Presentation

The presentation slides shall be obtainable on https://ir.alk.net shortly earlier than the assembly begins.

ALK-Abelló A/S

For additional info please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, cellular +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

About ALK
ALK is a worldwide specialty pharmaceutical firm centered on allergy and allergic bronchial asthma. It markets allergy immunotherapy therapies and different services and products for individuals with allergy and allergy medical doctors. Headquartered in Hørsholm, Denmark, ALK employs round 2,900 individuals worldwide and is listed on Nasdaq Copenhagen. Discover extra info at www.alk.internet.

Attachment